This means that individuals may inadvertently be exposing themselves to unknown harmful effects, by taking this drug without fully understanding the dangers associated with it
Saliu JA, Oboh G, Omojokun OS, Rocha JB, Schetinger MR, Guterries J, et al
Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist for type 2 diabetes and weight management, which works by suppressing appetite, slowing gastric emptying, increasing feelings of fullness, and reducing calorie intake
Vascular disease: L-Carnitine has been shown to improve blood flow and reduce inflammation in people with peripheral arterial disease, a condition that can lead to reduced blood flow to the limbs
Dapagliflozin also reduced the risk of heart failure in patients without a history of atherosclerotic cardiovascular disease (159)
This framework encourages evaluation of DDGS beyond nutrient supply and toward their potential effects on immune signaling, microbial ecology, and intestinal barrier function